Clinical Trials
2 trialsNCT05683834 2026-04-22
Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00359411 2017-07-02
Genetic Studies of X-linked Lymphoproliferative Disease
National Institutes of Health Clinical Center (CC)
Completed